4 ms·
I was asking what it was. I'm in the UK and am not familiar with this issue despite the same medication being available here
by easytiger 7y ago
I was asking what it was. I'm in the UK and am not familiar with this issue despite the same medication being available here
- mehrdadn 7y agoIf you're genuinely interested, there's so much reading on this. I'll quote one snippet here for you. Just to give you an idea. (This is not an invitation to reply to it and debate the issue. Just trying provide a pointer for reading more on the topic since you expressed interest.) > The drugmaker admitted in 2007, when confronted with evidence gathered by prosecutors, that it trained sales representative to tell doctors that OxyContin was less addictive and prone to abuse than competing opioids, claims beyond the one approved by the F.D.A. https://www.nytimes.com/2018/05/29/health/purdue-opioids-oxycontin.html https://www.nytimes.com/2018/05/29/health/purdue-opioids-oxy...